EMPLOYMENT AGREEMENTEmployment Agreement • June 24th, 2022 • Renovacor, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
Contract Type FiledJune 24th, 2022 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (this “Agreement”) is made, entered into by and between Renovacor, Inc., a Delaware corporation (the “Company”), and Joe Carroll (the “Executive”), dated June 17, 2022 (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 28th, 2022 • Renovacor, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
Contract Type FiledMarch 28th, 2022 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (this “Agreement”) is made, entered into by and between Renovacor, Inc., a Delaware corporation (the “Company”), and Fred Driscoll (the “Executive”), dated March 3, 2022.
EMPLOYMENT AGREEMENTEmployment Agreement • September 9th, 2021 • Renovacor, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
Contract Type FiledSeptember 9th, 2021 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (this “Agreement”) is made, entered into by and between Renovacor, Inc., a Delaware corporation (the “Company”), Matthew Killeen, PhD (the “Executive”), dated August 16, 2021.
EMPLOYMENT AGREEMENTEmployment Agreement • September 9th, 2021 • Renovacor, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
Contract Type FiledSeptember 9th, 2021 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (this “Agreement”) is made, entered into by and between Renovacor, Inc., a Delaware corporation (the “Company”), and Marc Semigran, MD (the “Executive”), dated May 5, 2021.
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • September 9th, 2021 • Renovacor, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
Contract Type FiledSeptember 9th, 2021 Company Industry JurisdictionThis AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is made, entered into by and between Renovacor, Inc., a Delaware corporation (the “Company”), and Magdalene Cook (the “Executive”), dated May 17th, 2021. The Agreement becomes effective upon the closing (the “Closing”) of the transactions (the “Merger”) contemplated by the Agreement and Plan of Merger by and among the Chardan Healthcare Acquisition 2 Corp. (“CHAQ”), CHAQ2 Merger Sub, Inc., and the Company dated March 22, 2021 (the “Merger Agreement”). The Closing date is also referred to in this Agreement as the “Effective Date.” For the avoidance of doubt, if the Closing does not occur, this Agreement shall be void ab initio, and the Original Employment Agreement shall remain in effect in accordance with its terms.